Skip to main content
Published locations for Pembrolizumab Plus Neoadjuvant Chemotherapy Improves Pathologic Complete Response Rates in Triple-Negative Breast Cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Pembrolizumab Plus Neoadjuvant Chemotherapy Improves Pathologic Complete Response Rates in Triple-Negative Breast Cancer
User login
Username
Password
Reset your password
/content/pembrolizumab-plus-neoadjuvant-chemotherapy-improves-pathologic-complete-response-rates
/jcomjournal/article/219572/oncology/pembrolizumab-plus-neoadjuvant-chemotherapy-improves-pathologic